Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

5 Apr 2022 16:35

RNS Number : 3743H
ABCAM PLC
05 April 2022
 

For immediate release

05 April 2022

ABCAM PLC

("Abcam" or the "Company")

Non-Executive Director Remuneration

Director/PDMR Shareholding Notification

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Peter Allen

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£ 14.36403

4,684

e)

Aggregated information

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.36403

4,684

£67,281.12

f)

Date of the transaction

04 April 2022

g)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Giles Kerr

2

Reason for the notification

a)

Position/status

Senior Independent Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£ 14.36403

1,719

e)

Aggregated information

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.36403

1,719

£24,691.77

f)

Date of the transaction

04 April 2022

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ms Mara Aspinall

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£ 14.36403

3,037

e)

Aggregated information

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.36403

3,037

£43,623.56

f)

Date of the transaction

04 April 2022

g)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Mark Capone

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£ 14.36403

1,584

e)

Aggregated information

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.36403

1,584

£22,752.62

f)

Date of the transaction

04 April 2022

g)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ms Bessie Lee

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£ 14.36403

1,019

e)

Aggregated information

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.36403

1,019

£14,636.95

f)

Date of the transaction

04 April 2022

g)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ms Sally Crawford

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£ 14.36403

609

e)

Aggregated information

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.36403

609

£8,747.69

f)

Date of the transaction

04 April 2022

g)

Place of the transaction

London Stock Exchange, AIM

 

 

Forward-Looking Statements

 

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this announcement that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding award eligibility and LTIP issuance and value sufficiency under the laws of the United Kingdom, as well as statements that include the words "expect," "intend," "plan," "believe," "project," "forecast," "estimate," "may," "should," "anticipate" and similar statements of a future or forward-looking nature. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation: a regional or global health pandemic, including the novel coronavirus ("COVID-19"), which has adversely affected elements of our business, could severely affect our business, including due to impacts on our operations and supply chains; challenges in implementing our strategies for revenue growth in light of competitive challenges; developing new products and enhancing existing products, adapting to significant technological change and responding to the introduction of new products by competitors to remain competitive; failing to successfully identify or integrate acquired businesses or assets into our operations or fully recognize the anticipated benefits of businesses or assets that we acquire; if our customers discontinue or spend less on research, development, production or other scientific endeavours; and the important factors discussed under the caption "Risk Factors" in Abcam's prospectus pursuant to Rule 424(b) filed with the U.S. Securities and Exchange Commission ("SEC") on 22 October 2020, which is on file with the SEC and is available on the SEC website at www.sec.gov, as such factors may be updated from time to time in Abcam's other filings with the SEC. Any forward-looking statements contained in this announcement speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. Abcam disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEELFBLZLXBBL
Date   Source Headline
14th Dec 20227:00 amRNSCancellation - Abcam Plc
12th Dec 20228:00 amRNSUpdate on AIM Delisting
9th Dec 20225:30 pmRNSAbcam
8th Dec 20222:36 pmRNSHolding(s) in Company
30th Nov 20228:55 amRNSTotal Voting Rights
28th Nov 20222:21 pmRNSDirector/PDMR Shareholding - Correction
28th Nov 20222:21 pmRNSDirector/PDMR Shareholding - Correction
17th Nov 20223:59 pmRNSDirector/PDMR Shareholding
17th Nov 20223:57 pmRNSDirector/PDMR Shareholding
11th Nov 20223:30 pmRNSResult of General Meeting
31st Oct 20223:22 pmRNSTotal Voting Rights
17th Oct 20227:00 amRNSPropose cancellation of AIM shares notice of GM
17th Oct 20227:00 amRNSProposed cancellation of AIM shares & notice of GM
10th Oct 20224:45 pmRNSDirector/PDMR Shareholding
10th Oct 20222:01 pmRNSDirector/PDMR Shareholding
10th Oct 20221:59 pmRNSDirector/PDMR Shareholding
30th Sep 20223:50 pmRNSBlock Listing Six Monthly Return
30th Sep 20223:48 pmRNSTotal Voting Rights
12th Sep 202212:00 pmRNSInterim results for the period ended 30 June 2022
12th Sep 20227:00 amRNSAppointment of Non-Executive Director
1st Sep 20222:02 pmRNSAbcam attend Morgan Stanley Healthcare Conference
31st Aug 202211:16 amRNSTotal Voting Rights
17th Aug 20228:30 amRNSNotice of Results
29th Jul 202211:09 amRNSTotal Voting Rights
20th Jul 202212:00 pmRNSTrading Statement
4th Jul 20228:36 amRNSTotal Voting Rights
31st May 20224:22 pmRNSTotal Voting Rights
18th May 20224:30 pmRNSResult of AGM
3rd May 202212:41 pmRNSDirector/PDMR Shareholding
29th Apr 20224:01 pmRNSTotal Voting Rights
5th Apr 20224:35 pmRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSPublication of 2021 ARA and Notice of AGM
31st Mar 202210:58 amRNSTotal Voting Rights
30th Mar 20222:41 pmRNSBlock listing Interim Review
28th Mar 20223:09 pmRNSBlock Listing application of Ordinary Shares
17th Mar 20221:18 pmRNSDirector/PDMR Shareholding Notification
14th Mar 202212:00 pmRNSResults for the period ended 31 December 2021
2nd Mar 20227:00 amRNSTotal Voting Rights
28th Feb 20227:00 amRNSNotice of Full Year Results
4th Feb 202212:02 pmRNSDirector/PDMR Shareholding
31st Jan 202211:49 amRNSTotal Voting Rights
27th Jan 202212:00 pmRNSTrading Statement
31st Dec 202112:49 pmRNSTotal Voting Rights
2nd Dec 20217:00 amRNSUpdate on 2021 General Meeting Resolution Vote
30th Nov 20213:25 pmRNSTotal Voting Rights
12th Nov 20215:28 pmRNSIssue of Equity and Replacement PDMR Notification
12th Nov 20214:17 pmRNSTotal Voting Rights
12th Nov 202112:34 pmRNSIssue of Equity and Replacement PDMR Notification
10th Nov 20214:56 pmRNSIssue of Equity and PDMR Notification
5th Nov 20213:19 pmRNSVesting of All Employee Share Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.